Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Labow

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Surgical Oncology|July 6, 2013
Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderlyParissa Tabrizian, Ghalib Jibara, Brian Shrager, et al.
American Journal of Surgery|May 10, 2008
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experienceManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Hepato-Gastroenterology|March 18, 2011
Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experienceManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Surgery|February 23, 2008
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcomeManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Annals of Surgical Oncology|July 30, 2022
Postoperative Respiratory Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy is Associated with Volume of Intraoperative Crystalloid Administration and Worse SurvivalEric Pletcher, Da Eun Cha, Elizabeth Gleeson, et al.
Journal of Surgical Oncology|June 7, 2022
Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgeryRebekah C Macfie, Da Eun Cha, Elizabeth Gleeson, et al.
Biomarkers in Medicine|July 22, 2021
Lymphocyte-to-monocyte ratio predicts survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyEric Pletcher, Elizabeth Gleeson, Tali Shaltiel, et al.
Hepatology (Baltimore, Md.)|May 12, 2012
Resection of hepatocellular cancer ≤2 cm: results from two Western centersSasan Roayaie, Khaled Obeidat, Carlo Sposito, et al.
Journal of Surgical Oncology|September 11, 2024
Impact of Previous Abdominal Surgery and Timing of Peritoneal Metastases on Accuracy of Imaging in Predicting the Surgical PCI: A Report From the PRECINCT StudyAditi Bhatt, Pascal Rousset, Brendan J Moran, et al.
Annals of Surgical Oncology|December 25, 2019
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database AnalysisEliahu Bekhor, Jacquelyn Carr, Margaret Hofstedt, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Surgical Oncology|July 6, 2013
Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderlyParissa Tabrizian, Ghalib Jibara, Brian Shrager, et al.
American Journal of Surgery|May 10, 2008
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experienceManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Hepato-Gastroenterology|March 18, 2011
Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experienceManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Surgery|February 23, 2008
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcomeManousos M Konstadoulakis, Sasan Roayaie, Ilias P Gomatos, et al.
Annals of Surgical Oncology|July 30, 2022
Postoperative Respiratory Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy is Associated with Volume of Intraoperative Crystalloid Administration and Worse SurvivalEric Pletcher, Da Eun Cha, Elizabeth Gleeson, et al.
Journal of Surgical Oncology|June 7, 2022
Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgeryRebekah C Macfie, Da Eun Cha, Elizabeth Gleeson, et al.
Biomarkers in Medicine|July 22, 2021
Lymphocyte-to-monocyte ratio predicts survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapyEric Pletcher, Elizabeth Gleeson, Tali Shaltiel, et al.
Hepatology (Baltimore, Md.)|May 12, 2012
Resection of hepatocellular cancer ≤2 cm: results from two Western centersSasan Roayaie, Khaled Obeidat, Carlo Sposito, et al.
Journal of Surgical Oncology|September 11, 2024
Impact of Previous Abdominal Surgery and Timing of Peritoneal Metastases on Accuracy of Imaging in Predicting the Surgical PCI: A Report From the PRECINCT StudyAditi Bhatt, Pascal Rousset, Brendan J Moran, et al.
Annals of Surgical Oncology|December 25, 2019
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database AnalysisEliahu Bekhor, Jacquelyn Carr, Margaret Hofstedt, et al.
Pageof 4